Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma

Area of Science:

• Hematology
• Oncology
• Molecular Genetics

Background:

• Genetics is crucial for risk stratification in plasma cell myeloma, guiding therapeutic decisions.
• Understanding the interplay between bone marrow morphology and genetic aberrations is vital for accurate prognosis.

Purpose of the Study:

• To investigate the correlation between bone marrow morphologic features and genetic aberrations in plasma cell myeloma.
• To establish the association between morphologic findings and gene expression profiles (MyPRS), chromosomal alterations, and gene mutations.

Main Methods:

• Analysis of bone marrow morphologic features, including plasma cell volume, growth pattern, cell maturity, mitotic index, and reticulin fibrosis.
• Correlation with genetic data: gene expression profiles (MyPRS), translocations, and gene mutations.
• Investigation of the combined effect of TP53 mutation and 17p loss on histological changes.

Main Results:

• High plasma cell volume, diffuse sheet growth, immature morphology, high mitotic index, and increased fibrosis significantly correlate with high-risk disease (MyPRS).
• MyPRS risk stratification is associated with specific chromosomal alterations and gene mutations.
• The combination of TP53 mutation and 17p loss shows a demonstrable effect on bone marrow histology.

Conclusions:

• Bone marrow morphologic features can effectively identify high-risk plasma cell myeloma patients when correlated with genetic profiles.
• This study provides novel insights into the relationship between histology and genetics, enhancing risk stratification.
• Findings support the integration of morphologic and genetic analyses for improved therapeutic guidance in plasma cell myeloma.